Illinois Medicaid Expands Access To Long-Acting Injectable Medications
Illinois Medicaid Expands Access To Long-Acting Injectable Medications
Provisions included in the Illinois annual Medicaid omnibus legislation require the medical assistance program to separately reimburse for long-acting injectable antipsychotic (LAIA) medications for mental health or substance use disorder treatment in the hospital inpatient setting.1 According to the Illinois Health and Hospital Association, the hope is this new provision in Public Act 102-0043 may expand access to evidence-based behavioral health treatments for Medicaid patients. The new law goes into effect on January …